BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AZD1163 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AZD1163\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07276581-6198@assetmemo.bio
DTSTAMP:20261121T005820Z
DTSTART;VALUE=DATE:20271112
DTEND;VALUE=DATE:20271113
SUMMARY:AZD1163: Phase 2 readout est. (NCT07276581)
DESCRIPTION:AZD1163\, phase 2\, Rheumatoid Arthritis.\nStudy: A Study to In
 vestigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid A
 rthritis\nEstimated primary completion: 12 November 2027. This is a Clinic
 alTrials.gov estimate\, not a confirmed readout date\, and it can move.\nD
 rug page: https://assetmemo.bio/drug/azd1163#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07276581
URL:https://assetmemo.bio/drug/azd1163#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
